Source:http://linkedlifedata.com/resource/pubmed/id/19054674
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-12-26
|
pubmed:abstractText |
A dual activity, conjugated approach has been taken to form hybrid molecules of two known antimalarial drugs, chloroquine (CQ) and the non-sedating H1 antagonist astemizole. A variety of linkers were investigated to conjugate the two agents into one molecule. Compounds 5-8 possessed improved in vitro activity against a CQ-resistant strain of Plasmodium falciparum, and examples 7 and 8 were active in vivo in mouse models of malaria.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1464-3405
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
481-4
|
pubmed:meshHeading |
pubmed-meshheading:19054674-Animals,
pubmed-meshheading:19054674-Antimalarials,
pubmed-meshheading:19054674-Astemizole,
pubmed-meshheading:19054674-Chloroquine,
pubmed-meshheading:19054674-Disease Models, Animal,
pubmed-meshheading:19054674-Drug Evaluation, Preclinical,
pubmed-meshheading:19054674-Malaria, Falciparum,
pubmed-meshheading:19054674-Mice,
pubmed-meshheading:19054674-Plasmodium falciparum
|
pubmed:year |
2009
|
pubmed:articleTitle |
Chloroquine-astemizole hybrids with potent in vitro and in vivo antiplasmodial activity.
|
pubmed:affiliation |
Department of Chemistry, University of Cape Town, P/B Rondebosch 7700, Cape Town, South Africa.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|